Jan 5, 2022 Addus HealthCare has entered into an agreement to acquire JourneyCare in a $85,000,000 deal. Addus HealthCare based at Palatine, Illinois, United States. […]
Kind Therapeutics USA acquired by MariMed
Jan 5, 2022 MariMed has entered into an agreement to acquire Kind Therapeutics USA in a $20,000,000 deal. MariMed based at Norwood, Massachusetts, United States. […]
Callahan Chemical Company acquired by Tilley-Phoenix Group
Jan 5, 2022 Tilley-Phoenix Group has entered into an agreement to acquire Callahan Chemical Company . Tilley-Phoenix Group based at Baltimore, Maryland, United States. ” […]
Series A – AvengeBio
On Jan 5, 2022 AvengeBio closed a Series A round and raised $45,000,000 from CAM Capital, Longitude Capital, Pappas Capital, Perceptive Advisors, Rock Springs Capital, […]
Pre Seed Round – BioShumm
On Jan 5, 2022 BioShumm closed a Pre-Seed round and raised $15,000 from HMG Invest, featuring lead investors HMG Invest. About the company: BioShumm is […]
Series C – Life Biosciences
On Jan 5, 2022 Life Biosciences closed a Series C round and raised $82,000,000 from Alpha Wave Ventures, George Godula, featuring lead investors Alpha Wave […]
Post-IPO Debt – Innate Pharma
On Jan 5, 2022 Innate Pharma closed a Post-IPO Debt round and raised €28,700,000 from BNP Paribas, Societe Generale, featuring lead investors . About the […]
Seed Round – Protai
On Jan 5, 2022 Protai closed a Seed round and raised $8,000,000 from Grove Ventures, Pitango Venture Capital, featuring lead investors Grove Ventures, Pitango Venture […]
Series B – Korro Bio
On Jan 5, 2022 Korro Bio closed a Series B round and raised $116,000,000 from Alexandria Venture Investments, Atlas Venture, Cormorant Asset Management, Eventide Asset […]
Series B – SalioGen Therapeutics
On Jan 5, 2022 SalioGen Therapeutics closed a Series B round and raised $115,000,000 from Cystic Fibrosis Foundation, D1 Capital Partners, EPIQ Capital Group, Fidelity […]
